Effects of 5-phenyloxazolidinedione on sodium-potassium-magnesium-activated adenosine triphosphatase activity in mouse brain.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000818:Animals; D000927:Anticonvulsants; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D002247:Carbon Isotopes; D055598:Chemical Phenomena; D002621:Chemistry; D004789:Enzyme Activation; D005260:Female; D007097:Imines; D007659:Ketones / Q000138:chemical synthesis; D007928:Lethal Dose 50; D008274:Magnesium / Q000494:pharmacology; D051379:Mice; D010042:Ouabain / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010080:Oxazoles / Q000097:blood / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D011188:Potassium / Q000494:pharmacology; D012640:Seizures / Q000188:drug therapy; D012964:Sodium / Q000494:pharmacology; D014293:Trimethadione / Q000494:pharmacology
D000927:Anticonvulsants; D002247:Carbon Isotopes; D007097:Imines; D007659:Ketones; D010080:Oxazoles; D010042:Ouabain; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D014293:Trimethadione; D011188:Potassium